Tzura、Kangmei Pharmaceutical、Hengrui Pharmaceuticals ranked in the top three in the top 20 of China's most competitive pharmaceutical listed company in 2012。"The 4th China Most Competitive Pharmaceutical Listed Company was selected recently in Beijing，2012 Most Investment Value Pharmaceutical Listed Company 10 selection was announced at the same time。Selection is sponsored stake betting appstake sports betting appby the China Medical Enterprise Management Association，Medical Manager Magazine and He Jun Consulting Group hosted。
According to the score from high to low,，2012 China's most competitive pharmaceutical listed company 20 is: Tasses、Kangmei Pharmaceutical、Hengrui Medicine、Chinese Medicine Holdings、Fosun Medicine、Chinese Medicine Holdings、East Ejiao、Mai Rui Medical、Alier Eye Department、Weigao shares、Chinese biopharmaceutical、Yibai Pharmaceutical、Shanghai Medicine、Huahai Pharmaceutical、Tongrentang、Renfu Medicine、Shuanglu Pharmaceutical、Keron Industry、Renhe Pharmaceutical、Xinhua Medical。
The top 10 list of the most investment value pharmaceutical listed companies in 2012 is: Yunnan Baiyao、Hengrui Medicine、Tzuhiki、Kangmei Pharmaceutical、Pianzai、Chinese Medicine Holdings、East Ejiao、China Resources Three Nine、Mai Rui Medical、Enhua Pharmaceutical (this ranking is not divided)。
The selection was launched in March 2012，Lotten 4 months to 193 in Shanghai、Shenzhen、Hong Kong、Singapore、New York、Nasdaq's annual sales of Chinese pharmaceutical companies with an annual stake sports betting appstake betting appsales of more than 100 million yuan conducted financial report analysis。The company's sales revenue in the past year、profit、Total market value and sales growth、profit growth、Market value increase、Net asset yield、Nine indicators of asset -liability ratio and flow ratio as the basic data，constitutes industrial dimension、Management dimension and capital dimension，Then calculate the score through weighted，accounting for 68%of the total score of the selection。The rest of the score of 32%of the total score of the selection is by the manager's dimension (manager quality、Management team) and resource dimension (shareholder resources、Unique) Composition，Through industry experts、Senior securities analysts and mainstream financial media reporter questionnaires Summary。
According to the organizer's introduction，To guide more pharmaceutical companies to pay attention to and correctly understand the power of capital，Scientific and reasonable use of capital，Promoting the healthy and rapid development of the industry，September this year，"2012 Chinese Pharmaceutical Entrepreneur Annual Conference and the Fourth Chinese Medical stake online sports bettingMy stake betting appListed Company Competitiveness 20 Awards Ceremony" will be held in Tianjin。At that time，The organizer will invite executives of listed companies and non -listed companies in the pharmaceutical industry，and the government、Capital、The executives of foreign -funded enterprises jointly develop in -depth exchanges around the theme of "asking 10 billion pharmaceutical companies"。
The competitiveness selection of listed companies in China is the fourth session this year，Due to the scientific rationality of the evaluation system、Selection procedure is objective and fair、Selection results strong orientation，I have won the recognition and positive evaluation of many listed companies and the industry。Tracking the results of the first two sessions，Pharmaceutical listed companies on the list have shown faster growth，and give back the value for shareholders。The top 20 competitiveness of the first pharmaceutical listed company in 2009 reached 28.12%，The average return on the top 10 investment value of the most investment value reached 37.95%; the average rate of return in the second pharmaceutical listed company in the second year of the 208.41%was 28.41%，The average Stake Sports Bettingstake sports betting appyield of the top 10 investment value is 36.60%，all significantly exceeded the overall yield of the A -share market and the pharmaceutical sector during the same period。
